Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Zedge
ZDGE
$40.5M
| $1.06M | ﹤0.01% |
603,014
-69,178
| -10% | -$150K |
|
2502
Dimensional International High Profitability ETF
DIHP
$6.47B
| $1.05M | ﹤0.01% |
+47,800
| New | +$1.02M |
|
2503
Identive
INVE
$61.2M
| $1.05M | ﹤0.01% |
145,352
-13,300
| -8% | -$129K |
|
|
ALYA
2504
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $1.05M | ﹤0.01% |
701,132
-24,000
| -3% | -$41.4K |
|
2505
Ceco Environmental
CECO
$4.01B
| $1.05M | ﹤0.01% |
89,983
-129,100
| -59% | -$1.46M |
|
2506
Fuel Tech
FTEK
$42.8M
| $1.05M | ﹤0.01% |
822,587
+46,171
| +6% | +$59.2K |
|
|
CASA
2507
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $1.05M | ﹤0.01% |
383,400
-14,800
| -4% | -$43.4K |
|
2508
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
| $1.04M | ﹤0.01% |
12,500
+5,700
| +84% | +$480K |
|
2509
Alkami Technology
ALKT
$2.11B
| $1.04M | ﹤0.01% |
+71,500
| New | +$997K |
|
2510
Axos Financial
AX
$5.78B
| $1.04M | ﹤0.01% |
27,300
-49,300
| -64% | -$1.88M |
|
2511
State Street SPDR S&P International Small Cap ETF
GWX
$904M
| $1.04M | ﹤0.01% |
+35,400
| New | +$1M |
|
2512
Pixelworks
PXLW
$40.6M
| $1.04M | ﹤0.01% |
49,025
-3,417
| -7% | -$61.1K |
|
|
PSTX
2513
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.04M | ﹤0.01% |
196,300
-147,000
| -43% | -$672K |
|
|
HLGN
2514
DELISTED
Heliogen, Inc.
HLGN
| $1.04M | ﹤0.01% |
+42,480
| New | +$1.92M |
|
|
NEXN
2515
Nexxen International
NEXN
$610M
| $1.03M | ﹤0.01% |
160,400
-60,400
| -27% | -$442K |
|
2516
Assured Guaranty
AGO
$3.66B
| $1.03M | ﹤0.01% |
+16,575
| New | +$983K |
|
2517
Stereotaxis
STXS
$135M
| $1.03M | ﹤0.01% |
498,600
-58,900
| -11% | -$115K |
|
2518
Alaunos Therapeutics
TCRT
$4.86M
| $1.02M | ﹤0.01% |
+10,525
| New | +$1.53M |
|
2519
Oceaneering
OII
$4.9B
| $1.02M | ﹤0.01% |
58,500
-49,000
| -46% | -$651K |
|
2520
AdaptHealth
AHCO
$806M
| $1.02M | ﹤0.01% |
53,165
-105,800
| -67% | -$2.24M |
|
2521
World Kinect Corp
WKC
$1.9B
| $1.02M | ﹤0.01% |
37,400
-18,500
| -33% | -$497K |
|
|
ZIMV
2522
DELISTED
ZimVie
ZIMV
| $1.02M | ﹤0.01% |
108,900
+42,500
| +64% | +$371K |
|
2523
MainStreet Bancshares
MNSB
$171M
| $1.02M | ﹤0.01% |
36,968
+18,912
| +105% | +$510K |
|
|
LCI
2524
DELISTED
Lannett Company, Inc.
LCI
| $1.02M | ﹤0.01% |
487,620
-21,174
| -4% | -$45.6K |
|
2525
Maui Land & Pineapple Co
MLP
$336M
| $1.01M | ﹤0.01% |
107,749
-8,400
| -7% | -$75.3K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.